维普中文期刊产品整合服务
406篇 您的检索式:作者名="Colao"
    题名 作者 年代 出处 被引量
1Hepatic steatosis,low-grade chronic inflammation and hormone/growth factor/adipokine imbalance显示文摘Non-alcoholic fatty liver disease (NAFLD), a further expression of metabolic syndrome, strictly linked to obesity and diabetes mellitus, is characterized by insulin resistance (IR), elevated serum levels of free fatty acids and fatty infi ltration of the liver, which is known as hepatic steatosis. Hepatocyte apoptosis is a key feature of this disease and correlates with its severity. Free-fatty-acidinduced toxicity represents one of mechanisms for the pathogenesis of NAFLD and hormones, growth factors and adipokines influence also play a key role. This review highlights the various pathways that contribute to the development of hepatic steatosis. Circulating concentrations of inflammatory cytokines are reckoned to be the most important factor in causing and maintaining IR. Low-grade chronic inflammation is fundamental in the progression of NAFLD toward higher risk cirrhotic states.Giovanni Tarantino Silvia Savastano Annamaria Colao 2010World Journal of Gastroenterology2010,16,38:22
2Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease显示文摘AIM: To shed some light on the relationship between anti-apoptotic serum Bcl-2 concentrations and metabolic status, anthropometric parameters, inflammation indices, and non-alcoholic fatty liver disease severity were investigated in 43 young individuals with fatty liver (FL)and 41 with nonalcoholic steatohepatitis (NASH).METHODS: Circulating levels of Bcl-2 were detected in 84 patients with ultrasono graphic findings of 'bright liver' and/or hyper-transaminasemia of unknown origin and/or increase in γ-glutamyl-transpeptidase (γ-GT)strictly in the absence of other acute or chronic liver disease, whose age was not advanced, who gave consent to liver biopsy and were then divided on the basis of the histological results into two groups (43 with FL and 41 with NASH). Twenty lean subjects, apparently healthy and young, were chosen as controls.RESULTS: Serum Bcl-2 concentrations were significantly higher in the FL group than in the NASH group. Insulin resistance and γ-GT activity were significantly higher in NASH subjects. Apoptotic hepatocytes were significantly more numerous in NASH patients. NASH patients presented with larger spleens and augmented C-reactive protein (CRP) concentrations than healthy subjects. Steatosis grade at histology was similar in both NASH and FL populations. The number of apoptotic cells was significantly related to anti-apoptotic Bcl-2 protein values in FL patients. Bcl-2 serum levels positively correlated to body mass index (BMI) values (P ≤ 0.0001) but not to age of the population. Triglycerides/HDL ratio correlated well to waist circumference in males (P = 0.0008).γ-GT activity was associated with homeostatic metabolic assessment (HOMA) (P = 0.0003) and with serum ferritin (P = 0.02). Bcl-2 concentrations were not related to either spleen size or CRP values. NASH patients presented a weak negative correlation between lobular inflammation and Bcl-2 levels. A prediction by low values of serum Bcl-2 towards a greater presence of metaboli-cally unhealthy overweight/obese patients (MUOs) was evidenced. HOMA, BMI and uric acid, in that sequence,best predicted serum Bcl-2 concentrations.CONCLUSION: MUOs could be detected by Bcl-2 levels.By favoring the life span of hepatocytes, and enhancing triglyceride formation, the anti-apoptotic process inhibits free fatty acids toxicity in FL.Giovanni Tarantino Francesco Scopacasa Annamaria Colao Domenico Capone Marianna Tarantino Ernesto Grimaldi Silvia Savastano 2011World Journal of Gastroenterology2011,17,48:10
3Hepatic steatosis in overweight/obese females: New screening method for those at risk显示文摘AIM: To identify which parameters could help to distinguish the 'metabolically benign obesity', which is not accompanied by insulin resistance (IR) and early atherosclerosis.METHODS: Eighty two of 124 overweight/obese females formed the study population, which was divided into two groups (52 and 30 subjects, respectively) with and without IR according to a HO meostatic Metabolic Assessment (HOMA) cut-off of 2, and were studied in a cross-sectional manner. The main outcome measures were waist circumference, serum uric acid, high-density lipoprotein-cholesterol and triglycerides, alanine amino-transferase, blood pressure and the two imaging para-meters, hepatic steatosis and longitudinal diameter of the spleen, which were measured in relation to the presence/absence of IR. RESULTS: A variable grade of visceral obesity was observed in all subjects with the exception of three.Obesity of a severe grade was represented more in the group of IR individuals (P = 0.01). Hepatic steatosis, revealed at ultrasound, was more pronounced in IR than in non-IR subjects (P = 0.005). The two groups also demonstrated a clear difference in longitudinal spleen diameter and blood pressure, with raised and signif icant values in the IR group. Metabolic syndrome was frequent in the IR group, and was not modified when adjusted for menopause (P = 0.001). At linear regression, the β values of waist circumference and body mass index predicting HOMA were 0.295, P = 0.007 and 0.41, P = 0.0001, respectively. Measures of spleen longitudinal diameter were well predicted by body mass index (BMI) values, β = 0.35, P = 0.01, and by HOMA, β = 0.41, P = 0.0001. Blood pressure was predicted by HOMA values, β = 0.39, P = 0.0001). HOMA and hepatic steatosis were highly associated (rho = 0.34, P = 0.002). Interestingly, IR patients were almost twice as likely to have hepatic steatosis as non-IR patients. Among the MS criteria, blood pressure was very accurate in identifying the presence of IR (AUROC for systolic blood pressure 0.66, cut-off 125 mm of Hg, sensibility 64%, specif icity 75%; AUROC for diastolic blood pressure 0.70, cut-off 85 mm of Hg, sensibility 54.5%, specif icity 75%). CONCLUSION: As health care costs are skyrocketing, reliable and mainly inexpensive tools are advisable to better defi ne subjects who really need to lose weight.Giovanni Tarantino Genoveffa Pizza Annamaria Colao Fabrizio Pasanisi Paolo Conca Patrizia Colicchio Carmine Finelli Franco Contaldo Carolina Di Somma Silvia Savastano 2009World Journal of Gastroenterology2009,15,45:4
4Spleen:A new role ffoorr an old player?显示文摘The spleen could be considered a neglected organ.To date,it has been deemed an ancillary organ in portal hypertension or an organ localization in lymphoproliferative diseases,even though it has had significant attention in infectious diseases for some time.Now,it is thought to be central in regulating the immune system,a metabolic asset and involved in endocrine function with regard to nonalcoholic fatty liver disease.The main mechanisms involved in this complex network will be critically discussed in this article.Giovanni Tarantino Silvia Savastano Domenico Capone Annamaria Colao 2011World Journal of Gastroenterology2011,17,33:2
5Long term effects of depot longacting somatostatin analog octreotide on hormone levels and tumour mass in acromegaly 显示文摘Colao A Ferone D Marzullo P 2001J Clin Endocrinol Metab2001,86,6:1
6The GH-- IGF-- I axis and the cardiovascular system : clin- ical implications显示文摘Colao A 2008Clin Endocrinol (oxf)2008,69,3:1
7Cardiovascular aspects in acromegaly: effects of treatment 显示文摘Lombardi G Colao A Ferone D 1996Metabolism1996,45,81:1
8Long-term effects of depot longacting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly 显示文摘Colao A Ferone D Marzullo P 2001J Clin Endocrinol Metab2001,86,6:1
9Does a gender-related effect of growth hormone(GH)replacement exist on cardiovascular risk factors,cardiac morphology,and performance and atherosclerosis?Results of a two-year open,prospective study in young adult men and women with se-vere GH deficiency显示文摘Colao A Di Somma C Cuocolo A 2005J Clin Endocrinol Metab2005,90,:1
10An implicit method for funding common solutions of variational inequalities and systems of equilibrium problems and fixed points of infinite family of nonexpansive mappings显示文摘Colao V Acedo G L Marino G 2009Nonlinear Anal2009,71,78:1
11Heterologous expression of lcc 1 gene from Trametes trogii in Pichia pastoris and characterization of the recombinant enzyme 显示文摘Colao MC Lupino S Garzillo AM 2006Microb Cell Fact2006,5,:1
12Structural and kinetic characterization of native laccases from Pleurotus ostreatus,Rigidoporus lignosus and Trametes trogii显示文摘GARZILLO A M COLAO M C BUONOCORE V 2001Journal of Protein Chemistry2001,20,3:1
13Orbital scintigraphy with -octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy显示文摘Colao A Lastoria S Ferone D 1998J Clin Endocrinol Metab1998,83,11:1
14Inferior petrosal sinus sampling in the differential diagnosis of Cushing's syndrome:results of an Italian muhicenter study 显示文摘Colao A Faggiano A Pivonello R 2001Eur J Endocrinol2001,144,5:1
15Effect of different dopaminergic agents in the treatment of acromegaly显示文摘Colao A Ferone D Marzullo P 1997J clin Endocrinol Metab1997,82,2:1
16An iterative method for finding common solutions of equilibrium problem and fixed point problems显示文摘Colao V Marino G Xu H K 2008J Math Anal Appl2008,344,1:1
17Minimally invasive osteosynthesis in stable trochanteric fractures:a comparative study between Gotfried percutaneous compression plate and Gamma 3 intramedullarynail显示文摘Varela Egocheaga JR Iglesias Colao R Suarez-Suarez MA 2009Arch Orthop Trauma Surg2009,129,10:1
18A 12-month phase 3 study of pasireotide in Cushing's disease 显示文摘Colao A Petersenn S Newell-Price J 2012N Engl J Med2012,366,10:1
19Medical treatment of prolactinomas显示文摘Colao A Savastano S 2011NatRev Endocrinol2011,7,5:1
20Surgical com- plications associated with the endoscopic endonasal trans- sphenoidal approach for pituitary adenomas 显示文摘Cappabianca P Cavallo LM Colao A 2002Neuro- surg2002,97,2:1
返回顶部 每页显示:
共21页 首页 上一页 第1页 下一页 末页 /21 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费